Product Information
METHYLPHENIDATE 30 MG/9 HR PATCH is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $8.7564 per EA under NDC 00378826393. Its NADAC has been published 175 times since Feb 22, 2023.
Strength
3.3 mg/h
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378826393
Classification
Generic
Dosage Form
PATCH
Route
TRANSDERMAL
Last Updated
6/17/2026
Active Ingredients
METHYLPHENIDATEApproval Type
Generic (ANDA)
FDA Application
ANDA206497On Market Since
6/27/2022
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE 30 MG/9 HR PATCH has been published 175 times since Feb 22, 2023, and over the history we have for it it has declined 32.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.7564 per EA |
|---|---|
| All-time high | $12.9826 (May 10, 2023) |
| All-time low | $8.6465 (Apr 22, 2026) |
| 52-week high | $9.7948 |
| 52-week low | $8.6465 |
| Median price | $9.7493 |
| Average price | $10.5873 |
| Largest weekly change | -9.0% (Jul 17, 2024) |
| Weeks tracked | 175 |
| Tracking since | Feb 22, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Methylphenidate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE 30 MG/9 HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 30 MG/9 HR PATCH, manufactured by Mylan Pharmaceuticals Inc., is $8.7564 per EA (NDC 00378826393), effective Jun 24, 2026.
How has the price of METHYLPHENIDATE 30 MG/9 HR PATCH changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE 30 MG/9 HR PATCH has declined 32.6%. It has been tracked across 175 weekly CMS publications since Feb 22, 2023.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 30 MG/9 HR PATCH?
Since Feb 22, 2023, the NADAC for METHYLPHENIDATE 30 MG/9 HR PATCH has ranged from a low of $8.6465 (Apr 22, 2026) to a high of $12.9826 (May 10, 2023), with a median of $9.7493 per EA.
Are there cheaper alternatives to METHYLPHENIDATE 30 MG/9 HR PATCH?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of METHYLPHENIDATE 30 MG/9 HR PATCH, so no direct lower-cost alternative is listed.
Who manufactures METHYLPHENIDATE 30 MG/9 HR PATCH?
METHYLPHENIDATE 30 MG/9 HR PATCH (NDC 00378826393) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification